Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Frontline Bioventures (hong Kong) Limited

Frontline Bioventures (hong Kong) Limited

Institutional venture firmHong Kong6dimensionscapital.comSEC venture capital fund adviserpart of 6 Dimensions Capital

One of 2 advisers that share 6dimensionscapital.com; the firm is 6 Dimensions Capital. 6 Dimensions Capital. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

venture manager, reported GAV $74M across 1 vehicles

Importance
12
low
Active deployment
0
low
Emerging
0
low
Completeness
38
elevated
Freshness
97
high
Research priority
4
low
Identity and regulatory footprint
Headquarters
Hong Kong, Hong Kongadviserinfo.sec.gov
Office address
#6706, THE CENTER, 99 QUEEN'S RD CENTRAL, CENTRAL, Hong Kongadviserinfo.sec.gov
Business phone
852 2805 1580adviserinfo.sec.gov
Website
HTTP://6DIMENSIONSCAPITAL.COM
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 28, 2024
Private funds reported
1 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$74.2Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
852 2805 1580adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
China Life Sciences Access Fund, L.P.FundunknownUnknown$74.2M
Mar 28, 2024
20$0
of $80.0M
Feb 27, 2013
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 1 departed
Lianyong Chen
Director & Member · since Feb 1, 2012
Principal
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SAU Yin Chung
Director & Member · since Sep 1, 2020
Principal
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
1 departed (kept with end dates)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
8 relationships from shared deals, counted for the whole firm
HLC Vgc Management IV Limited 1 shared · one time01vc Advisor Ltd 1 shared · one timeMonolith Venture Advisory Limited 1 shared · one time5y Capital Management Limited 1 shared · one timeBanyan Capital Partners Ltd. 1 shared · one timeXiang He Management Services, Inc. 1 shared · one timeBLC Advisors, Ltd. 1 shared · one timeQiming 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. Mar 31, 2020
    Qingsheng Zhu (Member) no longer on Schedule A of Frontline Bioventures (hong Kong) Limited
    Person leftPeopleInferenceQingsheng ZhuSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Jun 11, 2018
    Frontline Bioventures (hong Kong) Limited first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Jun 11, 2018
    China Life Sciences Access Fund, L.P. first reported on Form ADV by Frontline Bioventures (hong Kong) Limited (Venture Capital Fund), GAV $99,127,483
    Fund first reported on Form ADVFundsFactChina Life Sciences Access Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $74M across 1 vehicles
Evidence
21 observations from 1 source
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2018-06-11Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-28Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone852 2805 1580Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersHong Kong, Hong KongMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address#6706, THE CENTER, 99 QUEEN'S RD CENTRAL, CENTRAL, Hong KongMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formOther (specify)Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported1Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$74.2MMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported1Mar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://6DIMENSIONSCAPITAL.COMMar 28, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)